Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-037131
Filing Date
2025-03-11
Accepted
2025-03-11 16:06:10
Documents
104
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K dnth-20241231.htm   iXBRL 10-K 3123673
2 EX-19.1 dnth-ex19_1.htm EX-19.1 123493
3 EX-23.1 dnth-ex23_1.htm EX-23.1 3897
4 EX-31.1 dnth-ex31_1.htm EX-31.1 18621
5 EX-31.2 dnth-ex31_2.htm EX-31.2 17927
6 EX-32.1 dnth-ex32_1.htm EX-32.1 15261
7 GRAPHIC img101679919_0.jpg GRAPHIC 24984
8 GRAPHIC img208539054_0.jpg GRAPHIC 433837
9 GRAPHIC img208539054_1.jpg GRAPHIC 113794
10 GRAPHIC img208539054_2.jpg GRAPHIC 63984
11 GRAPHIC img208539054_3.jpg GRAPHIC 150999
12 GRAPHIC img208539054_4.jpg GRAPHIC 18989
13 GRAPHIC img208539054_5.jpg GRAPHIC 11769
14 GRAPHIC img208539054_6.jpg GRAPHIC 33605
  Complete submission text file 0000950170-25-037131.txt   14984085

Data Files

Seq Description Document Type Size
15 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT dnth-20241231.xsd EX-101.SCH 1785767
107 EXTRACTED XBRL INSTANCE DOCUMENT dnth-20241231_htm.xml XML 2307329
Mailing Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036
Business Address 7 TIMES SQUARE 43RD FLOOR NEW YORK NY 10036 929-999-4055
Dianthus Therapeutics, Inc. /DE/ (Filer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38541 | Film No.: 25727573
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)